Letter by Shah Regarding Article, “Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)”
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.